Does CABOTEGRAVIR Cause Decreased appetite? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Decreased appetite have been filed in association with CABOTEGRAVIR (Apretude). This represents 0.3% of all adverse event reports for CABOTEGRAVIR.
27
Reports of Decreased appetite with CABOTEGRAVIR
0.3%
of all CABOTEGRAVIR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Decreased appetite From CABOTEGRAVIR?
Of the 27 reports, 2 (7.4%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for CABOTEGRAVIR.
What Other Side Effects Does CABOTEGRAVIR Cause?
Product dose omission issue (1,121)
Off label use (1,049)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which CABOTEGRAVIR Alternatives Have Lower Decreased appetite Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL